FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,610 letters match. Newest first.

  1. NewSelf Limited dba NewSelf

    FDA warns NewSelf over misleading website claims for compounded semaglutide and tirzepatide, including false compounder and FDA-approval implications.

    Low
  2. Alan Health Technologies Inc. dba Alan

    FDA warns Alan Health Technologies over website falsely labeling compounded semaglutide and tirzepatide as Alan-made.

    Low
  3. Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics

    FDA warned Deluxe IV and Aesthetics over misleading website claims for compounded semaglutide and tirzepatide, including implying FDA approval.

    Low
  4. Aspen Aesthetics dba Fifty 410

    FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.

    Low
  5. Black Sheep Egg Company, LLC

    Black Sheep Egg Company in Walnut Ridge, Arkansas, found Salmonella throughout its shell egg plant and insanitary conditions.

    High risk
  6. Diasol, Inc.

    Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.

    High risk
  7. GenoGenix LLC

    FDA warns GenoGenix over insanitary sterile compounding, endotoxin-contaminated NAD+, and unapproved drugs.

    High risk
  8. R.R. Importaciones Inc.

    FDA found R.R. Importaciones Inc. lacked required foreign food supplier verification, including for chocolate.

    Medium
  9. The Father's Table, LLC

    FDA warned The Father's Table that its ready-to-eat cheesecakes and cake rolls were adulterated after Listeria monocytogenes was found in the facility.

    High risk
  10. Yuyao City Boss Vegetable Factory Co. Ltd.

    Yuyao City Boss Vegetable Factory failed to keep or fabricated processing records for U.S.-shipped acidified mustard stems.

    High risk
  11. Supercan Bully Sticks LLC

    Supercan Bully Sticks lacked a foreign supplier verification program and written food safety plan after Salmonella recall of pig ear treats.

    High risk
  12. A. Nelson & Co. Ltd.

    London homeopathic drug maker A. Nelson & Co. shipped children's products without microbial testing and discarded quality records.

    High risk
  13. AQ USA Inc., d.b.a Ross Healthcare Inc.

    FDA warns AQ USA/Ross Healthcare over current good manufacturing practice violations in drugs, including missing microbial testing and inadequate component and stability controls.

    High risk
  14. ExThera Medical Corporation

    ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.

    High risk
  15. Beta Bionics, Inc.

    FDA says Beta Bionics' iLet Bionic Pancreas system had quality-system failures, including ignored complaints of severe hypoglycemia and diabetic ketoacidosis.

    High risk
  16. East CK Trading Inc.

    East CK Trading lacked an FSVP for imported ginseng, wolfberry, and mushroom seasoning, FDA says.

    Medium
  17. Cosmetic Manufacturers Pty Ltd.

    FDA warned Cosmetic Manufacturers Pty Ltd. that its Australian drug site was adulterated due to CGMP violations and placed its drugs on import alert.

    High risk
  18. Fidelity Melon, Inc

    FDA warns Fidelity Melon for lacking foreign supplier verification for imported melons.

    Medium
  19. Bio-Medical Pharmaceutical Manufacturing Corporation

    Bio-Medical Pharmaceutical Manufacturing, a Houston contract manufacturer, was cited for sterile OTC drug current good manufacturing practice (CGMP) failures and drug listing violations.

    High risk
  20. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  21. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  22. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  23. Signature Formulations, LLC

    FDA says Signature Formulations made OTC drugs on shared equipment without adequate controls, risking hormone contamination.

    High risk
  24. Boothwyn Pharmacy, LLC

    Boothwyn Pharmacy made sterile drugs in insanitary conditions and shipped lots that failed sterility and potency tests.

    High risk
  25. Maui Seafood LLC

    Maui Seafood LLC's Las Vegas RTE tuna and salmon plant had Listeria monocytogenes (a harmful bacterium) and seafood safety plan sanitation violations.

    High risk
  26. Cohance Lifesciences Limited

    Cohance Lifesciences, a finished-drug maker, was cited for inadequate investigations and dirty shared equipment that caused cross-contamination.

    High risk
  27. HTO Nevada, Inc. dba Kirkman

    HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.

    High risk
  28. Abbott Diabetes Care, Inc.

    FDA warns Abbott Diabetes Care that FreeStyle Libre 3 glucose monitors lacked design transfer and finished-device accuracy release testing.

    High risk
  29. Christopher Dale Butler

    FDA warned Christopher Dale Butler that his pickled quail egg products lacked required acidified-food process controls and were deemed adulterated (unsafe under the law).

    High risk
  30. Unomedical Device S.A. de C.V.

    FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.

    High risk
  31. Carolina Seafood Inc.

    FDA warned Carolina Seafood that its ready-to-eat crab and shrimp dips had inadequate seafood hazard-control plans.

    High risk
  32. Zip Foods Importers, Inc

    Zip Foods Importers lacked required foreign supplier verification programs for many imported foods, FDA found.

    Medium
  33. Fulijaya Manufacturing SDN. BHD.

    Fulijaya Manufacturing in Malaysia failed CGMP (drug manufacturing rules) for OTC drugs, with missing lab data, flawed microbial tests, and weak stability data.

    High risk
  34. Center For Immunology Science, LLC

    FDA cites Center for Immunology Science for a clinical trial of heat-killed Mycobacterium smegmatis without an Investigational New Drug application.

    High risk
  35. Meridian Bioscience, Inc

    FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.

    High risk
  36. MAST Biosurgery USA, Inc.

    MAST Biosurgery USA never ran promised endotoxin tests on its SurgiWrap FROST surgical mesh and failed to report patient injuries, FDA says.

    High risk
  37. Asli Foods, Inc

    Asli Foods, a food importer, lacked required foreign supplier checks for chocolate, tea, and kabab mix, FDA says.

    Medium
  38. MG GROUP USA

    MG GROUP USA lacked FSVP records for imported truffle oil and fresh truffles, FDA found during an August 2025 inspection.

    Medium
  39. American Food Distributor Inc.

    FDA warns American Food Distributor for missing FSVP for imported tahina, olive oil, and mallow leaves.

    Medium
  40. Prodrome Sciences USA, LLC

    Prodrome Sciences studied its supplement ProdromeNeuro Oil as a dementia drug in 29 people without first filing an IND, FDA says.

    High risk
  41. Genetrace

    FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.

    High risk
  42. Integrity Partners Group

    FDA warns Integrity Partners Group about manufacturing failures at its Chemisphere drug plant, including inadequate testing, supplier verification, cleaning, and process validation.

    High risk
  43. Winder Laboratories, LLC

    FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.

    High risk
  44. LXR Biotech, LLC

    FDA warns LXR Biotech over CGMP (manufacturing quality rules) failures for Eternal Energy supplements, making them adulterated (legally unfit as made).

    Medium
  45. Chemspec Chemicals Private Limited

    FDA warns Indian API maker Chemspec Chemicals over missing batch records and data integrity failures.

    High risk
  46. Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital

    FDA warned Senthil Specialty Hospital and Dr. Purushothaman Damodara Kumaran about missed safety monitoring in a bioequivalence study of an investigational drug.

    High risk
  47. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  48. Pan-African Food Distributors Inc./East Africa Boutique LLC

    FDA found widespread rodent and insect infestation in Pan-African Food Distributors’ warehouse holding dietary supplements, foods and cosmetics.

    High risk
  49. Middle East/Soli's Baking Company, Inc. dba Middle East Baking Co.

    FDA found live insects and rodent droppings throughout Middle East Baking's pita and bagel plant in Burlingame, California.

    High risk
  50. Absolutely Natural

    FDA warned Absolutely Natural of Melbourne, Florida, over nonprescription drug manufacturing violations, including weak contamination investigations and component testing.

    High risk